Form D Explorer

Form D — Areteia Therapeutics, Inc.

0001937542-25-000001 · filed Feb 21, 2025

Offering

Industry: Biotechnology
Exemptions: 06b
Total offering: $445,000,000
Total sold: $360,000,020
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Areteia Therapeutics, Inc.
CIK: 1937542
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2022
Address: 101 GLEN LENNOX DR.
CHAPEL HILL, NC 27517
Phone: 617-504-0362

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Paul Berns · Director

Chapel Hill, NC Find on LinkedIn ↗
Adam Koppel · Director

Chapel Hill, NC Find on LinkedIn ↗
Ian Read · Director

Chapel Hill, NC Find on LinkedIn ↗
Benjamin Gomez · Director

Chapel Hill, NC Find on LinkedIn ↗
Michael E. Bozik · Director

Chapel Hill, NC Find on LinkedIn ↗
Stephen Butts · Director

Chapel Hill, NC Find on LinkedIn ↗
Jorge Bartolome · Executive Officer

Chapel Hill, NC Find on LinkedIn ↗
Elyse Stock · Director

Chapel Hill, NC Find on LinkedIn ↗
Daniel Becker · Director

Chapel Hill, NC Find on LinkedIn ↗
Christopher Courts · Executive Officer

Chapel Hill, NC Find on LinkedIn ↗
Robin Walker · Executive Officer

Chapel Hill, NC Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗